Dr Sharon Cunningham

Lecturer
Medicine, Children's Medical Research Institute

Telephone 96872800

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Cunningham, S., Kok, C., Spinoulas, A., Carpenter, K., Alexander, I. (2013). AAV-encoded OTC activity persisting to adulthood following delivery to newborn spfash mice is insufficient to prevent shRNA-induced hyperammonaemia. Gene Therapy, 20(12), 1184-1187. [More Information]
  • Kok, C., Cunningham, S., Carpenter, K., Dane, A., Siew, S., Logan, G., Kuchel, P., Alexander, I. (2013). Adeno-associated Virus-mediated Rescue of Neonatal Lethality in Argininosuccinate Synthetase-deficient Mice. Molecular Therapy, 21(10), 1823-1831. [More Information]
  • Dane, A., Wowro, S., Cunningham, S., Alexander, I. (2013). Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes. Gene Therapy, 20(4), 460-464. [More Information]
  • Alexander, I., Kok, C., Dane, A., Cunningham, S. (2012). Gene therapy for metabolic disorders: an overview with a focus on urea cycle disorders. Journal of Inherited Metabolic Disease (JIMD), 35(4), 641-645. [More Information]
  • Cunningham, S., Kok, C., Dane, A., Carpenter, K., Kizana, E., Kuchel, P., Alexander, I. (2011). Induction and Prevention of Severe Hyperammonemia in the spf(ash) Mouse Model of Ornithine Transcarbamylase Deficiency Using shRNA and rAAV-mediated Gene Delivery. Molecular Therapy, 19(5), 854-859. [More Information]
  • Fleming, J., Spinoulas, A., Zheng, M., Cunningham, S., Ginn, S., McQuilty, R., Rowe, P., Alexander, I. (2005). Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors. Human Gene Therapy, 16(8), 947-956. [More Information]

2013

  • Cunningham, S., Kok, C., Spinoulas, A., Carpenter, K., Alexander, I. (2013). AAV-encoded OTC activity persisting to adulthood following delivery to newborn spfash mice is insufficient to prevent shRNA-induced hyperammonaemia. Gene Therapy, 20(12), 1184-1187. [More Information]
  • Kok, C., Cunningham, S., Carpenter, K., Dane, A., Siew, S., Logan, G., Kuchel, P., Alexander, I. (2013). Adeno-associated Virus-mediated Rescue of Neonatal Lethality in Argininosuccinate Synthetase-deficient Mice. Molecular Therapy, 21(10), 1823-1831. [More Information]
  • Dane, A., Wowro, S., Cunningham, S., Alexander, I. (2013). Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes. Gene Therapy, 20(4), 460-464. [More Information]

2012

  • Alexander, I., Kok, C., Dane, A., Cunningham, S. (2012). Gene therapy for metabolic disorders: an overview with a focus on urea cycle disorders. Journal of Inherited Metabolic Disease (JIMD), 35(4), 641-645. [More Information]

2011

  • Cunningham, S., Kok, C., Dane, A., Carpenter, K., Kizana, E., Kuchel, P., Alexander, I. (2011). Induction and Prevention of Severe Hyperammonemia in the spf(ash) Mouse Model of Ornithine Transcarbamylase Deficiency Using shRNA and rAAV-mediated Gene Delivery. Molecular Therapy, 19(5), 854-859. [More Information]

2005

  • Fleming, J., Spinoulas, A., Zheng, M., Cunningham, S., Ginn, S., McQuilty, R., Rowe, P., Alexander, I. (2005). Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors. Human Gene Therapy, 16(8), 947-956. [More Information]

To update your profile click here. For support on your academic profile contact .